A detailed history of Berger Financial Group, Inc transactions in Bio Techne Corp stock. As of the latest transaction made, Berger Financial Group, Inc holds 31,375 shares of TECH stock, worth $2.24 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
31,375
Previous 39,994 21.55%
Holding current value
$2.24 Million
Previous $3.09 Million 28.43%
% of portfolio
0.21%
Previous 0.34%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$65.98 - $77.09 $568,681 - $664,438
-8,619 Reduced 21.55%
31,375 $2.21 Million
Q4 2023

Feb 07, 2024

SELL
$52.83 - $78.22 $200,225 - $296,453
-3,790 Reduced 8.66%
39,994 $3.09 Million
Q3 2023

Nov 03, 2023

BUY
$67.52 - $89.42 $2,768 - $3,666
41 Added 0.09%
43,784 $2.98 Million
Q2 2023

Aug 10, 2023

BUY
$73.76 - $85.98 $221 - $257
3 Added 0.01%
43,743 $3.57 Million
Q4 2022

Jan 30, 2023

BUY
$80.67 - $352.29 $2.65 Million - $11.6 Million
32,804 Added 299.96%
43,740 $3.63 Million
Q3 2022

Oct 27, 2022

SELL
$282.54 - $391.85 $452,064 - $626,960
-1,600 Reduced 12.76%
10,936 $3.11 Million
Q2 2022

Aug 08, 2022

BUY
$322.67 - $449.65 $645 - $899
2 Added 0.02%
12,536 $4.35 Million
Q1 2022

May 10, 2022

SELL
$353.85 - $487.79 $849,947 - $1.17 Million
-2,402 Reduced 16.08%
12,534 $5.43 Million
Q4 2021

Jan 26, 2022

SELL
$456.15 - $525.06 $534,607 - $615,370
-1,172 Reduced 7.28%
14,936 $7.73 Million
Q3 2021

Oct 28, 2021

SELL
$444.87 - $538.88 $2.95 Million - $3.57 Million
-6,632 Reduced 29.16%
16,108 $7.81 Million
Q2 2021

Jul 29, 2021

SELL
$387.35 - $450.26 $77,470 - $90,052
-200 Reduced 0.87%
22,740 $10.2 Million
Q4 2020

Feb 02, 2021

BUY
$246.9 - $321.87 $5.66 Million - $7.38 Million
22,940 New
22,940 $7.29 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.79B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Berger Financial Group, Inc Portfolio

Follow Berger Financial Group, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berger Financial Group, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berger Financial Group, Inc with notifications on news.